Skip to content
Prialt(ziconotide)
Prialt (ziconotide) is a protein pharmaceutical. Ziconotide was first approved as Prialt on 2004-12-28. It is used to treat chronic pain in the USA. It has been approved in Europe to treat pain and spinal injections. It is known to target voltage-dependent N-type calcium channel subunit alpha-1B and voltage-dependent P/Q-type calcium channel subunit alpha-1A.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
therapeuticsD013812
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Prialt
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ziconotide acetate
Tradename
Company
Number
Date
Products
PRIALTTerSera TherapeuticsN-021060 RX2004-12-28
3 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
prialtNew Drug Application2019-08-15
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
chronic painHP_0012532D059350—
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Ziconotide Acetate, Prialt, Tersera
86530332024-10-01U-48, U-55
87656802024-10-01U-48, U-55
97072702024-10-01U-2084
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02B: Other analgesics and antipyretics in atc
— N02BG: Other analgesics and antipyretics in atc
— N02BG08: Ziconotide
HCPCS
Code
Description
J2278
Injection, ziconotide, 1 microgram
Clinical
Clinical Trials
9 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeuralgiaD009437EFO_0009430—1—1—2
Spinal cord diseasesD013118HP_0002196G95.9———1—1
Peripheral nervous system diseasesD010523G64———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52—22—15
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80—2———2
Intractable painD010148—1———1
Hiv infectionsD015658EFO_0000764B20—1———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic painD059350HP_0012532————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameZICONOTIDE
INNziconotide
Description
Ziconotide, sold under the brand name Prialt, also called intrathecal ziconotide (ITZ) because of its administration route, is an atypical analgesic agent for the amelioration of severe and chronic pain. Derived from Conus magus, a cone snail, it is the synthetic form of an ω-conotoxin peptide. It is 1,000 times as powerful as morphine.
Classification
Protein
Drug classpeptides
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC3=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
Identifiers
PDB—
CAS-ID107452-89-1
RxCUI68503
ChEMBL IDCHEMBL4594214
ChEBI ID—
PubChem CID16135415
DrugBankDB06283
UNII ID7I64C51O16 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CACNA1B
CACNA1B
CACNA1A
CACNA1A
Organism
Homo sapiens
Gene name
CACNA1B
Gene synonyms
CACH5, CACNL1A5
NCBI Gene ID
774
Protein name
voltage-dependent N-type calcium channel subunit alpha-1B
Protein synonyms
BIII, Brain calcium channel III, calcium channel alpha12.2 subunit, calcium channel, L type, alpha-1 polypeptide, Calcium channel, L type, alpha-1 polypeptide isoform 5, calcium channel, voltage-dependent, L type, alpha 1B subunit, calcium channel, voltage-dependent, N type, alpha 1B subunit, Cav2.2 voltage-gated Ca2+ channel, voltage-gated calcium channel alpha subunit Cav2.2, Voltage-gated calcium channel subunit alpha Cav2.2
Uniprot ID
Q00975
Mouse ortholog
Cacna1b (12287)
voltage-dependent N-type calcium channel subunit alpha-1B (Q60609)
Variants
Clinical Variant
No data
Financial
Prialt - Elan Corporation
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Prialt - Jazz Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,219 documents
View more details
Safety
Black-box Warning
Black-box warning for: Prialt
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
12,183 adverse events reported
View more details